Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Shock, Septic | 3 | 2018 | 1313 | 1.01 | Why? |
| Matrix Metalloproteinase 8 | 1 | 2017 | 45 | 0.69 | Why? |
| Chemokine CCL3 | 1 | 2017 | 103 | 0.68 | Why? |
| Granzymes | 1 | 2017 | 197 | 0.66 | Why? |
| HSP70 Heat-Shock Proteins | 1 | 2017 | 113 | 0.65 | Why? |
| Daptomycin | 1 | 2017 | 64 | 0.63 | Why? |
| Interleukin-8 | 1 | 2017 | 964 | 0.44 | Why? |
| Staphylococcus aureus | 1 | 2017 | 844 | 0.41 | Why? |
| Brain Injuries, Traumatic | 3 | 2020 | 381 | 0.40 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.28 | Why? |
| RNA, Messenger | 1 | 2017 | 5131 | 0.25 | Why? |
| Emergency Medicine | 2 | 2010 | 936 | 0.24 | Why? |
| Genetic Predisposition to Disease | 1 | 2017 | 4027 | 0.23 | Why? |
| Ventricular Dysfunction, Left | 1 | 2010 | 993 | 0.23 | Why? |
| Sepsis | 1 | 2017 | 3517 | 0.21 | Why? |
| Glasgow Coma Scale | 2 | 2017 | 249 | 0.20 | Why? |
| Air Ambulances | 2 | 2017 | 202 | 0.20 | Why? |
| Employment | 1 | 2010 | 1754 | 0.18 | Why? |
| Recovery of Function | 2 | 2020 | 2461 | 0.18 | Why? |
| Isotonic Solutions | 1 | 2018 | 69 | 0.17 | Why? |
| Intracranial Hemorrhage, Traumatic | 1 | 2017 | 6 | 0.17 | Why? |
| Work | 1 | 2020 | 342 | 0.17 | Why? |
| Electrolytes | 1 | 2018 | 103 | 0.17 | Why? |
| Ultrasonography | 2 | 2010 | 4409 | 0.16 | Why? |
| Personnel, Hospital | 2 | 2020 | 2273 | 0.16 | Why? |
| Alcoholic Intoxication | 1 | 2017 | 77 | 0.16 | Why? |
| Point-of-Care Systems | 1 | 2010 | 2955 | 0.16 | Why? |
| Sodium Chloride | 1 | 2018 | 203 | 0.16 | Why? |
| Brain Concussion | 1 | 2017 | 113 | 0.15 | Why? |
| Acute Disease | 3 | 2018 | 6029 | 0.15 | Why? |
| Head | 1 | 2017 | 206 | 0.14 | Why? |
| Telecommunications | 1 | 2020 | 551 | 0.14 | Why? |
| End Stage Liver Disease | 1 | 2019 | 418 | 0.14 | Why? |
| Accident Prevention | 1 | 2013 | 10 | 0.14 | Why? |
| Transcriptome | 2 | 2018 | 3466 | 0.14 | Why? |
| Outpatients | 4 | 2021 | 3417 | 0.13 | Why? |
| Health Facilities | 2 | 2021 | 1230 | 0.12 | Why? |
| Fluid Therapy | 1 | 2018 | 628 | 0.12 | Why? |
| Sexual Partners | 1 | 2017 | 612 | 0.12 | Why? |
| Hospitalization | 8 | 2021 | 54280 | 0.12 | Why? |
| Language | 1 | 2018 | 655 | 0.12 | Why? |
| Bites and Stings | 1 | 2013 | 91 | 0.12 | Why? |
| Ambulatory Care | 2 | 2020 | 4947 | 0.11 | Why? |
| Transportation of Patients | 1 | 2017 | 494 | 0.11 | Why? |
| Emergency Treatment | 1 | 2018 | 719 | 0.11 | Why? |
| Ethanol | 1 | 2017 | 533 | 0.11 | Why? |
| Emergency Service, Hospital | 6 | 2018 | 14232 | 0.11 | Why? |
| United States | 13 | 2021 | 46150 | 0.11 | Why? |
| Healthy Volunteers | 1 | 2017 | 1444 | 0.11 | Why? |
| Body Surface Potential Mapping | 1 | 2009 | 20 | 0.10 | Why? |
| Tennessee | 2 | 2021 | 243 | 0.10 | Why? |
| Patient Transfer | 1 | 2017 | 898 | 0.10 | Why? |
| Environmental Exposure | 1 | 2020 | 1558 | 0.10 | Why? |
| Manikins | 2 | 2017 | 466 | 0.10 | Why? |
| Male | 27 | 2021 | 367725 | 0.10 | Why? |
| Models, Cardiovascular | 1 | 2010 | 153 | 0.10 | Why? |
| Female | 27 | 2021 | 380317 | 0.10 | Why? |
| Adult | 24 | 2021 | 244371 | 0.09 | Why? |
| Heart Failure | 1 | 2010 | 6638 | 0.09 | Why? |
| Aftercare | 1 | 2018 | 1637 | 0.09 | Why? |
| Clinical Decision-Making | 2 | 2019 | 3755 | 0.09 | Why? |
| Community-Acquired Infections | 1 | 2020 | 2328 | 0.09 | Why? |
| Humans | 38 | 2021 | 930598 | 0.09 | Why? |
| Middle Aged | 22 | 2021 | 270681 | 0.08 | Why? |
| Confined Spaces | 1 | 2006 | 37 | 0.08 | Why? |
| Out-of-Hospital Cardiac Arrest | 1 | 2017 | 1047 | 0.08 | Why? |
| Hydroxychloroquine | 2 | 2020 | 12447 | 0.08 | Why? |
| Academic Medical Centers | 4 | 2020 | 3088 | 0.08 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.08 | Why? |
| Age Factors | 2 | 2018 | 21039 | 0.08 | Why? |
| Gene Expression Profiling | 1 | 2017 | 3788 | 0.08 | Why? |
| Case-Control Studies | 3 | 2021 | 17671 | 0.07 | Why? |
| Hospitals, Community | 1 | 2010 | 475 | 0.07 | Why? |
| Caregivers | 1 | 2020 | 3112 | 0.07 | Why? |
| Quality of Life | 3 | 2021 | 9820 | 0.07 | Why? |
| Patient Care Team | 1 | 2019 | 3556 | 0.07 | Why? |
| ROC Curve | 1 | 2017 | 6024 | 0.07 | Why? |
| Job Satisfaction | 1 | 2010 | 647 | 0.07 | Why? |
| Child, Preschool | 3 | 2018 | 36283 | 0.07 | Why? |
| Infant | 2 | 2018 | 30274 | 0.07 | Why? |
| Hypolipidemic Agents | 1 | 2006 | 208 | 0.07 | Why? |
| Palliative Care | 1 | 2019 | 2665 | 0.07 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.07 | Why? |
| Reproducibility of Results | 2 | 2017 | 11304 | 0.06 | Why? |
| Cardiopulmonary Resuscitation | 1 | 2017 | 1876 | 0.06 | Why? |
| Social Support | 1 | 2017 | 3183 | 0.06 | Why? |
| Cardiac Catheterization | 1 | 2010 | 882 | 0.06 | Why? |
| Hospitals, Pediatric | 1 | 2013 | 1792 | 0.06 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.06 | Why? |
| Cholesterol | 1 | 2006 | 660 | 0.06 | Why? |
| Brain Ischemia | 1 | 2018 | 2813 | 0.06 | Why? |
| Aged | 13 | 2021 | 215776 | 0.06 | Why? |
| Young Adult | 8 | 2021 | 93724 | 0.06 | Why? |
| Hematologic Tests | 1 | 2006 | 521 | 0.06 | Why? |
| Health Education | 1 | 2013 | 1539 | 0.06 | Why? |
| Hospitals, Teaching | 1 | 2010 | 1609 | 0.06 | Why? |
| Fellowships and Scholarships | 1 | 2010 | 931 | 0.06 | Why? |
| Logistic Models | 2 | 2021 | 9089 | 0.05 | Why? |
| Myocardial Infarction | 1 | 2017 | 3361 | 0.05 | Why? |
| Magnetic Resonance Imaging | 1 | 2018 | 6551 | 0.05 | Why? |
| Electrocardiography | 2 | 2017 | 3957 | 0.05 | Why? |
| Adrenal Cortex Hormones | 1 | 2018 | 6537 | 0.05 | Why? |
| Adolescent | 6 | 2021 | 86841 | 0.05 | Why? |
| Contact Tracing | 1 | 2020 | 8448 | 0.05 | Why? |
| Cohort Studies | 2 | 2017 | 36005 | 0.05 | Why? |
| Self Efficacy | 1 | 2006 | 717 | 0.05 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.05 | Why? |
| Dyslipidemias | 1 | 2006 | 791 | 0.05 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.05 | Why? |
| Primary Health Care | 1 | 2018 | 4839 | 0.05 | Why? |
| Antibodies, Viral | 3 | 2021 | 51949 | 0.05 | Why? |
| Time Factors | 5 | 2021 | 31397 | 0.05 | Why? |
| Intracranial Pressure | 1 | 2019 | 90 | 0.05 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.05 | Why? |
| Ambulatory Care Facilities | 2 | 2020 | 2063 | 0.05 | Why? |
| Blood Pressure | 1 | 2010 | 2198 | 0.05 | Why? |
| Vaccines, Synthetic | 2 | 2021 | 3231 | 0.05 | Why? |
| Speech Therapy | 1 | 2019 | 152 | 0.04 | Why? |
| Controlled Before-After Studies | 1 | 2017 | 51 | 0.04 | Why? |
| Mass Screening | 1 | 2017 | 8005 | 0.04 | Why? |
| Urban Population | 2 | 2018 | 2000 | 0.04 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.04 | Why? |
| Risk Factors | 4 | 2020 | 71621 | 0.04 | Why? |
| Delivery of Health Care | 2 | 2021 | 15909 | 0.04 | Why? |
| Visual Analog Scale | 1 | 2017 | 151 | 0.04 | Why? |
| Brain Mapping | 1 | 2018 | 228 | 0.04 | Why? |
| Single-Blind Method | 1 | 2020 | 1283 | 0.04 | Why? |
| Occupational Therapy | 1 | 2019 | 228 | 0.04 | Why? |
| Intensive Care Units | 2 | 2020 | 29594 | 0.04 | Why? |
| Acute Coronary Syndrome | 1 | 2009 | 2107 | 0.04 | Why? |
| Referral and Consultation | 3 | 2019 | 4816 | 0.04 | Why? |
| Ohio | 1 | 2017 | 639 | 0.04 | Why? |
| Clinical Competence | 1 | 2010 | 3263 | 0.04 | Why? |
| Seroepidemiologic Studies | 2 | 2021 | 10017 | 0.04 | Why? |
| Substance Abuse Detection | 1 | 2017 | 192 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.03 | Why? |
| Cross-Over Studies | 1 | 2018 | 867 | 0.03 | Why? |
| Treatment Failure | 1 | 2020 | 2106 | 0.03 | Why? |
| Stroke | 1 | 2018 | 8839 | 0.03 | Why? |
| Prognosis | 1 | 2017 | 32490 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2017 | 88759 | 0.03 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.03 | Why? |
| Treatment Outcome | 4 | 2021 | 51732 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2021 | 2437 | 0.03 | Why? |
| Insurance Coverage | 1 | 2018 | 348 | 0.03 | Why? |
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2020 | 1316 | 0.03 | Why? |
| Reference Standards | 1 | 2017 | 1163 | 0.03 | Why? |
| Sensitivity and Specificity | 2 | 2010 | 22971 | 0.03 | Why? |
| Brain Injuries | 1 | 2017 | 374 | 0.03 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.03 | Why? |
| Television | 1 | 2013 | 224 | 0.03 | Why? |
| HIV Infections | 1 | 2017 | 11620 | 0.03 | Why? |
| Retrospective Studies | 3 | 2018 | 105322 | 0.03 | Why? |
| Vaccination Coverage | 1 | 2021 | 1249 | 0.03 | Why? |
| Computer Simulation | 1 | 2006 | 4982 | 0.03 | Why? |
| Hemodynamics | 1 | 2019 | 1562 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 1 | 2020 | 3776 | 0.03 | Why? |
| Physicians | 1 | 2010 | 4214 | 0.03 | Why? |
| Physical Therapy Modalities | 1 | 2019 | 1090 | 0.03 | Why? |
| Child | 2 | 2017 | 70012 | 0.03 | Why? |
| Prospective Studies | 4 | 2017 | 43301 | 0.03 | Why? |
| Appointments and Schedules | 1 | 2018 | 1204 | 0.02 | Why? |
| Patient Care | 1 | 2021 | 1664 | 0.02 | Why? |
| Severity of Illness Index | 1 | 2018 | 48226 | 0.02 | Why? |
| Renal Replacement Therapy | 1 | 2018 | 1530 | 0.02 | Why? |
| Computer Systems | 1 | 2009 | 255 | 0.02 | Why? |
| Surveys and Questionnaires | 2 | 2019 | 43792 | 0.02 | Why? |
| Antimalarials | 1 | 2020 | 2505 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.02 | Why? |
| Pilot Projects | 1 | 2019 | 5182 | 0.02 | Why? |
| Auditory Perception | 1 | 2006 | 32 | 0.02 | Why? |
| Task Performance and Analysis | 1 | 2006 | 68 | 0.02 | Why? |
| Kidney Diseases | 1 | 2018 | 1434 | 0.02 | Why? |
| Vibration | 1 | 2006 | 68 | 0.02 | Why? |
| Educational Technology | 1 | 2006 | 101 | 0.02 | Why? |
| Dogs | 1 | 2013 | 2529 | 0.02 | Why? |
| Family | 1 | 2020 | 2909 | 0.02 | Why? |
| Pandemics | 7 | 2020 | 389249 | 0.02 | Why? |
| Cross-Sectional Studies | 3 | 2020 | 53120 | 0.02 | Why? |
| Angioplasty, Balloon, Coronary | 1 | 2009 | 365 | 0.02 | Why? |
| Internship and Residency | 1 | 2006 | 4987 | 0.02 | Why? |
| Training Support | 1 | 2006 | 131 | 0.02 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.02 | Why? |
| Survival Rate | 1 | 2019 | 9206 | 0.02 | Why? |
| Noise | 1 | 2006 | 194 | 0.02 | Why? |
| Troponin T | 1 | 2009 | 771 | 0.02 | Why? |
| Creatinine | 1 | 2009 | 1443 | 0.02 | Why? |
| Socioeconomic Factors | 1 | 2020 | 8495 | 0.01 | Why? |
| Time-to-Treatment | 1 | 2019 | 5883 | 0.01 | Why? |
| Longitudinal Studies | 1 | 2018 | 9893 | 0.01 | Why? |
| Costs and Cost Analysis | 1 | 2006 | 694 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2021 | 10649 | 0.01 | Why? |
| Syndrome | 1 | 2006 | 1310 | 0.01 | Why? |
| Predictive Value of Tests | 1 | 2017 | 9537 | 0.01 | Why? |
| Coronary Disease | 1 | 2006 | 645 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.01 | Why? |
| Brain | 1 | 2018 | 5133 | 0.01 | Why? |
| Percutaneous Coronary Intervention | 1 | 2017 | 3646 | 0.01 | Why? |
| Curriculum | 1 | 2013 | 3083 | 0.01 | Why? |
| Length of Stay | 1 | 2017 | 11042 | 0.01 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.01 | Why? |
| Program Evaluation | 1 | 2006 | 1929 | 0.01 | Why? |
| Drug Prescriptions | 1 | 2006 | 1062 | 0.01 | Why? |
| Feasibility Studies | 1 | 2006 | 3467 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2013 | 8811 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2017 | 25144 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2006 | 17020 | 0.01 | Why? |
| Animals | 1 | 2013 | 78931 | 0.00 | Why? |
Lindsell's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(210)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(388)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_